EUVIMEDEUVIMED entdecken
Crossref

Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies

Lila Ramaiah iD, Tara Arndt iD, Gareth Thomas iD, Norimitsu Shirai iD, Manu Sebastian iD, Cory Sims iD, Steven Bailey iD

Toxicologic Pathology · 2025-08 · 53 (6) · 571-581

DOI: 10.1177/01926233251339113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicologic Pathology, online erschienen am 31.05.2025. Verfasst von Lila Ramaiah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson, Spring House, Pennsylvania, USA. Hauptthemen laut MEDLINE: Toxicology, Pathology, Pathology, Clinical, Toxicity Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toxicologic pathologists assess large data sets from nonclinical studies to identify treatment-related effects to assist in predicting human safety hazards. Statistical testing can facilitate data interpretation by highlighting group differences that have a low probability of random occurrence based on a pre-determined P -value cut-off (eg, P < .05). While this method has been used in the interpretation of pathology data for decades, the appropriateness of utilizing statistical testing in this way has been challenged. Here, we discuss common statistical pitfalls in the analysis of toxicologic pathology data, with emphasis on clinical pathology, reaffirming that appropriate use of statistical analysis requires an understanding of (1) the parameters assessed; (2) the inherent strengths and weaknesses of the statistical method used; and (3) that appropriate interpretation of pathology data is based on the pathologist’s expertise. The presence or absence of statistical significance should not supersede expert judgment but should be one of many tools used to reach a conclusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxicologyPathologyPathology, ClinicalToxicity TestsHumansData Interpretation, StatisticalAnimals

Stichwörter der Autor:innen

P-valuesanatomic pathologyclinical pathologyhazard evaluationsafety assessmentstatistical significancestatistics

Autor:innen und Institutionen

  • Johnson & Johnson, Spring House, Pennsylvania, USA.
  • AltaSciences Preclinical, Seattle, Washington, USA.
  • IQVIA, Reading, UK.
  • Vertex Pharmaceuticals, Boston, Massachusetts, USA.
  • MD Anderson Cancer Center, Houston, Texas, USA.
  • Independent Statistical Consultant (ret.), Underhill, Vermont, USA.

ORCID-Profile: Lila Ramaiah, Tara Arndt, Gareth Thomas, Norimitsu Shirai, Manu Sebastian, Cory Sims, Steven Bailey

Zitieren

APA

Ramaiah, L., Arndt, T., Thomas, G., Shirai, N., Sebastian, M., Sims, C., & Bailey, S. (2025). Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies. Toxicologic Pathology, 53(6), 571-581. https://doi.org/10.1177/01926233251339113

Vancouver

Ramaiah L, Arndt T, Thomas G, Shirai N, Sebastian M, Sims C, et al. Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies. Toxicologic Pathology. 2025;53(6):571-581. doi:10.1177/01926233251339113

BibTeX
@article{Ramaiah2025,
  author = {Ramaiah, Lila and Arndt, Tara and Thomas, Gareth and Shirai, Norimitsu and Sebastian, Manu and Sims, Cory and Bailey, Steven},
  title = {Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies},
  journal = {Toxicologic Pathology},
  year = {2025},
  volume = {53},
  number = {6},
  pages = {571--581},
  doi = {10.1177/01926233251339113}
}
Kostenlos starten →